|
|
Ceretec Journal Abstracts
- Inflammatory
bowel disease activity assessment using technetium-99m-HMPAO leukocytes.
Arndt JW, Grootscholten MI, van Hogezand RA, Griffioen G, Lamers CB, Pauwels
EK
- 99mTc-HMPAO
planar white cell scanning Weldon MJ
- Technetium-99m
hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease:
diagnostic and clinical relevance.Sciarretta G, Furno A, Mazzoni M, Basile
C, Malaguti P
- 99mTc-HMPAO
granulocyte scintigraphy in the early detection of postoperative asymptomatic
recurrence in Crohn's disease.Biancone L, Scopinaro F, Ierardi M, Paoluzi
P, Marcheggiano A, Di Paolo MC, Porowska B, Colella AC, Pallone F
- Investigating
inflammatory bowel disease--white cell scanning, radiology, and colonoscopy.Jobling
JC, Lindley KJ, Yousef Y, Gordon I, Milla PJ (This article concerns
the use of CERETEC (technetium Tc99m-labeled exametazime) for labeled white
blood cell (WBC) imaging in children. The use of Ceretec for WBC imaging in
children has not been approved by the Food and Drug Administration. CERETEC
is marketed by Amersham Health.)
- Distribution
of acute bowel inflammation determined by technetium-labeled white blood cells
in children with inflammatory bowel disease.Charron M, Fernando del Rosario
J, Kocoshis S (This article concerns the use of CERETEC (technetium
Tc99m-labeled exametazime) for labeled white blood cell (WBC) imaging in children.
The use of Ceretec for WBC imaging in children has not been approved by the
Food and Drug Administration. CERETEC is marketed by Amersham Health.)
- Instant
technetium 99m hexamethyl propylenamine oxime-labeled leukocyte scan compared
with colonoscopy in early assessment of disease extent and activity in acute
colitis.Stahlberg D, Mare K, Granqvist S, Agren B, Richter S, Lofberg R
|
|